APA (7th ed.) Citation

Hanan M. Alharbi, Taha Alqahtani, Ali H. Alamri, Vinoth Kumarasamy, Vetriselvan Subramaniyan, Vetriselvan Subramaniyan, & K. Suresh Babu. (2024). Nanotechnological synergy of mangiferin and curcumin in modulating PI3K/Akt/mTOR pathway: A novel front in ovarian cancer precision therapeutics. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Hanan M. Alharbi, Taha Alqahtani, Ali H. Alamri, Vinoth Kumarasamy, Vetriselvan Subramaniyan, Vetriselvan Subramaniyan, and K. Suresh Babu. Nanotechnological Synergy of Mangiferin and Curcumin in Modulating PI3K/Akt/mTOR Pathway: A Novel Front in Ovarian Cancer Precision Therapeutics. Frontiers Media S.A., 2024.

MLA (9th ed.) Citation

Hanan M. Alharbi, et al. Nanotechnological Synergy of Mangiferin and Curcumin in Modulating PI3K/Akt/mTOR Pathway: A Novel Front in Ovarian Cancer Precision Therapeutics. Frontiers Media S.A., 2024.